Zoher Ghogawala to Cost-Benefit Analysis
This is a "connection" page, showing publications Zoher Ghogawala has written about Cost-Benefit Analysis.
Connection Strength
0.887
-
Mummaneni PV, Whitmore RG, Curran JN, Ziewacz JE, Wadhwa R, Shaffrey CI, Asher AL, Heary RF, Cheng JS, Hurlbert RJ, Douglas AF, Smith JS, Malhotra NR, Dante SJ, Magge SN, Kaiser MG, Abbed KM, Resnick DK, Ghogawala Z. Cost-effectiveness of lumbar discectomy and single-level fusion for spondylolisthesis: experience with the NeuroPoint-SD registry. Neurosurg Focus. 2014 Jun; 36(6):E3.
Score: 0.413
-
Rihn JA, Bhat S, Grauer J, Harrop J, Ghogawala Z, Vaccaro AR, Hilibrand AS. Economic and Outcomes Analysis of Recalcitrant Cervical Radiculopathy: Is Nonsurgical Management or Surgery More Cost-Effective? J Am Acad Orthop Surg. 2019 Jul 15; 27(14):533-540.
Score: 0.147
-
Carreon LY, Glassman SD, Ghogawala Z, Mummaneni PV, McGirt MJ, Asher AL. Modeled cost-effectiveness of transforaminal lumbar interbody fusion compared with posterolateral fusion for spondylolisthesis using N(2)QOD data. J Neurosurg Spine. 2016 Jun; 24(6):916-21.
Score: 0.116
-
Resnick DK, Tosteson AN, Groman RF, Ghogawala Z. Setting the equation: establishing value in spine care. Spine (Phila Pa 1976). 2014 Oct 15; 39(22 Suppl 1):S43-50.
Score: 0.106
-
Ghogawala Z, Whitmore RG, Watters WC, Sharan A, Mummaneni PV, Dailey AT, Choudhri TF, Eck JC, Groff MW, Wang JC, Resnick DK, Dhall SS, Kaiser MG. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 3: assessment of economic outcome. J Neurosurg Spine. 2014 Jul; 21(1):14-22.
Score: 0.104